Cargando…
SAT-644 A Case of the Use of the Eversense Continuous Glucose Monitor with Repeated Same-Pocket Insertion
Introduction:The Eversense continuous glucose monitoring (ECGM) system is a 90-day implantable, subcutaneous device approved for patients with diabetes. The manufacturer recommends alternating arms for each subsequent insertion site to allow for appropriate healing. To date, there is few data descri...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208444/ http://dx.doi.org/10.1210/jendso/bvaa046.1846 |